Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Long-term benefits of induction therapy in NMO: a case report.
Tetracyclines inhibit human synovial collagenase in vivo and in vitro.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
From genes to characteristics of multiple sclerosis.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.
Effect of autoimmune diseases on risk and survival in female cancers.
Fluctuations of MS births and UV-light exposure.
Progressive multiple sclerosis: pathology and pathogenesis.
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
FDA Approves New Drug to Treat Psoriasis
Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Epithelial v-like antigen mediates efficacy of anti-alpha4 integrin treatment in a mouse model of multiple sclerosis.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Pages
« first
‹ previous
…
311
312
313
314
315
316
317
318
319
…
next ›
last »